MNKD
MANNKIND CORP
MANNKIND CORP (MNKD) has 15 SEC Form 4 filings (39 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 18, 2026.
Insiders have net sold $376K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Michael E. Castagna
- Employees:403
- HQ:Danbury, CA, US
- IPO:2004-07-28
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$376K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$1.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| EVP Genl Counsel & Secretary | Sale | 24,109 | $98K | Jul 18 | SEC ↗ | |
| Director | Sale | 52,485 | $213K | Jul 18 | SEC ↗ | |
Binder Steven B.First filing | Director | Sale | 16,940 | $56K | May 14 | SEC ↗ |
Thomson DavidFirst filing | EVP Genl Counsel & Secretary | Sale | 3,033 | $10K | May 14 | SEC ↗ |
Related companies
MANNKIND CORP is in the Healthcare sector.